MedPath

The effects of synbiotic supplementation on anti inflammatory index in lymphedema after breast cancer treatment

Phase 2
Recruiting
Conditions
ymphedema.
Registration Number
IRCT2017092023861N6
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
88
Inclusion Criteria

Women with unilateral Breast Cancer Related Lymphedema; breast cancer lymphedema in STAGE = 2; age range of 18-60 years; BMI between 25 and 35; At least one month has passed since the last treatment such as radiotherapy; willingness to participate in the study Non-inclusion criteria: use of multi-vitamin minerals and omega-3 supplements up to 1 month before the study began; acute and chronic infection; history of autoimmune diseases such as rheumatoid arthritis; Inflammatory diseases such as heart failure, pulmonary, kidney and diabetes; taking supplements of probiotics from 6 months before study; having a weight loss diet in Length 6 months before the study; Smoking and alcohol consumption; Lymphedema due to other cancers Exclusion criteria : Unwillingness of the patient to continue research collaboration; No subsequent referral; Cancer recurrence during the study; Failure to follow a weight loss diet; Consumption of food and supplements containing probiotics during the study; Incidence of edema-like diseases such as renal, cardiovascular and respiratory failure during the study period; Metastasis; Infectious diseases in Study length; Consumption of less than 56 capsules of 70 capsules at the end of the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IL-10. Timepoint: Before and after the intervention. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath